During the past decade, Centenario Hospital Miguel Hidalgo conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 12 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centenario Hospital Miguel Hidalgo" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Instituto Mexicano del Seguro Social" with 2 trials sponsored and "CENTOGENE GmbH Rostock" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centenario Hospital Miguel Hidalgo" #1 collaborator was "Centenario Hospital Miguel Hidalgo" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)" with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Centenario Hospital Miguel Hidalgo" are "Breast Cancer" (4 trials), "Acute Respiratory Failure" (1 trials), "COVID-19" (1 trials), "COVID-19 Pneumonia" (1 trials) and "Cerebral Circulatory Disorder" (1 trials). Many other conditions were trialed in "Centenario Hospital Miguel Hidalgo" in a lesser frequency.

Most popular intervention types in "Centenario Hospital Miguel Hidalgo" are "Drug" (16 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Docetaxel" (3 trials), "trastuzumab emtansine" (3 trials), "BI 685509" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centenario Hospital Miguel Hidalgo" are 17 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centenario Hospital Miguel Hidalgo". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Centenario Hospital Miguel Hidalgo, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centenario Hospital Miguel Hidalgo, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".